Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Boehringer Ingelheim (Spain) | Researchclopedia

Back to institutions

Boehringer Ingelheim (Spain)

Sant Cugatcompany

372

Works

15,527

Citations

64

h-index

Top Research Topics

Chronic Obstructive Pulmonary Disease (COPD) Research Monoclonal and Polyclonal Antibodies Research Diabetes Treatment and Management

Top Researchers

Nicholas G. Martin QIMR Berghofer Medical Research Institute

2,799 works233,125 citationsh-index: 221

Recent Research

Green Chemistry Articles of Interest to the Pharmaceutical Industry

Miles H. Aukland,Theresa Dutschei,et al.

20260 citations

Asthma and respiratory diseases

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Atrial Fibrillation Management and Outcomes

HER2/EGFR in Cancer Research

Respiratory Support and Mechanisms

Lung Cancer Treatments and Mutations

Health Systems, Economic Evaluations, Quality of Life

Protein purification and stability

Animal Disease Management and Epidemiology

Al B. Benson Northwestern University

812 works72,800 citationsh-index: 132

Hiroji Iwata Nagoya City University

834 works56,675 citationsh-index: 89

Hao Li University of Science and Technology of China

1,041 works32,114 citationsh-index: 87

Hua Li Shenyang Pharmaceutical University

1,437 works30,791 citationsh-index: 74

Liang Tong Qiqihar University

560 works26,776 citationsh-index: 91

Industry Practices in Monoclonal Antibody Tissue Biodistribution Assessment: An IQ Consortium Cross-Industry Survey of Current Approaches and Emerging Trends

Huaping Tang,Michael McCoy,et al.

20260 citations

Nickel/Photoredox-Catalyzed Enantioselective α-Aminoalkylation of 2-Iodopyridines

Zhen Lei,H. Ray Kelly,et al.

20260 citations

Abstract LB-A002: Open-label, Phase Ib dose-expansion study assessing the efficacy of the CD137/FAP agonist BI 765179 plus pembrolizumab as first-line therapy in metastatic or incurable, recurrent PD-L1-positive head and neck squamous cell carcinoma

Rachna T. Shroff,Dejan Radonjic,et al.

20260 citations

Abstract LB-A004: DAREON-7: Phase I open-label dose-escalation/-expansion study of first-line obrixtamig (BI 764532) plus chemotherapy in patients with DLL3-positive neuroendocrine carcinomas

Aman Chauhan,Saori Mishima,et al.

20260 citations

Nerandomilast paves the way for novel strategies in IPF drug discovery*

M J Thomas,F Herrmann,et al.

20260 citations